ReleaseWire Connect

Xarelto or the Rivaroxaban which is one of what is said to be the latest and best alternative anticoagulant medication in the market today has been reviewed just recently by Health Canada in terms of its safety. However, the safety review summary released last August 26 this year investigated Xarelto in two separate studies and was found out to be linked in the development of liver injury in the 16 subjects. The purpose of the research conducted by the department was focused on the possibilities of Xarelto increasing the risk for liver problems and injuries. However, they could not arrive at a conclusion to this hypothesis because some of the documentation contains incomplete information. But because of the allegations and controversial issues that Xarelto is being involved at, Health Canada decided to further study the drug and asked professional health care providers as well as the patients using Xarelto to document and report any incidences of liver injuries that could possibly be related to the anticoagulant drug being investigated.

There have been so many allegations that have been coming out that what Janssen Pharmaceuticals and Bayer Health Care claim to be the newest wonder anticoagulant drug; Xarelto is not at all effective so they say. In line with this, one of the latest lawsuits filed against the manufacturers and distributors of Xarelto was filed just lately in Philadelphia, Pennsylvania. As a matter of fact, Pennsylvania is the very first to make allegations against the Drug that is absolutely ineffective and useless in preventing ischemic strokes and that the drug may actually be the one to cause it especially in patients who have been found out to have atrial fibrillation even in the prescribed once a day dosage.

Thousands of people in the United States have filed cases against Johnson and Johnson, Bayer Heath Care and Janssen because of the allegations that Xarelto have been said to cause uncontrolled internal hemorrhages that led to the worsening of patients' conditions leading to life threatening complications and deaths. However, the people who have filed Xarelto Lawsuits have great concerns about the length of time the settlements would take after having formally filed the cases in January 2014.

There is wide range of anticoagulant medicines that have been used to treat patients with coagulant problems including those with cardiovascular diseases and other life-threatening medical conditions. However, patients who are using these blood thinners have to have their blood monitored and because of this, patients are required to be admitted to the hospital so that if ever adverse effects appear, antidotes could be given promptly to counteract the effects of the drug. And because the dosage depends on the laboratory results, patients have to be closely monitored as well. Moreover, patients who are taking blood thinners have constraints and dietary restrictions; and this makes it more inconvenient for patients.

Xarelto, a drug that has been designed to treat coagulation problems by acting as a proven effective blood thinner, has become the focus of the medical practitioners, consumers and most especially the Xarelto lawyers because of the disturbing number of patients who have experienced serious adverse effects that has put the lives of these people at risk; hence the drug has become tremendously controversial.

While patients and medical health professionals are at a look out for more effective and cost-efficient treatment for various disorders, drug manufacturers have the responsibility to provide the public with facts about the pharmaceutical and clinical trials for every drug and substance that is marketed for public consumption.

The focus on global health issues has become really tremendous as people get wiser and more scrupulous in choosing the products and services, especially when pertaining to health care. One of the most controversial issues that have really captured the attention of a massive number of people is the issues about a famous replacement for Warfarin as a blood thinner agent; the Xarelto.

Medical health professional practitioners should really be very careful in dealing with patients as misdosage or the choice of drugs to be prescribed to patients because certain substances and medications would greatly affect any human being; hence, this may produce irreversible disabling, serious medical conditions and worse, death.